BSX logo Boston Scientific Corporation +
Boston Scientific Corporation
+

Boston Scientific Corporation (BSX) Business News

Track Boston Scientific Corporation in real time with a live news feed covering Boston Scientific Corporation stock news, official press releases, company announcements, and an archive of historical Boston Scientific Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Artisan Value Fund Q2 2026 Portfolio Update

Seeking Alpha

11:25 AM | Tuesday | Jul 21, 2026

news photo
Loading...

US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.

Read full article redirect
11:25 AM | Tuesday | Jul 21, 2026

Artisan Value Fund Q2 2026 Portfolio Update

Seeking Alpha

US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.

Read full article arrow
News Thumbnail
10:51 AM | Tuesday | Jul 21, 2026

Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?

Zacks Investment Research

BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pressures and weak stock performance cloud the outlook.

Read full article arrow
News Thumbnail
3:11 AM | Saturday | Jul 18, 2026

Allspring Global Investments Holdings LLC Trims Stock Holdings in Boston Scientific Corporation $BSX

Defense World

Allspring Global Investments Holdings LLC reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 49.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,093,483 shares of the medical equipment provider's stock after selling 1,079,916 shares during the period. Allspring Global Investments Holdings

Read full article arrow
News Thumbnail
7:01 PM | Tuesday | Jul 14, 2026

Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research

In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from the previous day.

Read full article arrow
News Thumbnail
10:30 AM | Friday | Jul 10, 2026

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

Zacks Investment Research

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read full article arrow
News Thumbnail
2:15 AM | Thursday | Jul 9, 2026

Billionaire Steve Cohen Sold Amazon and Nvidia but Loaded Up on This Beaten-Down Stock

The Motley Fool

Amazon and Nvidia have been caught up in the AI trade, but have flatlined so far in 2026. Steve Cohen's Point72 Asset Management sold Amazon and Nvidia in the first quarter.

Read full article arrow
News Thumbnail
11:59 AM | Monday | Jul 6, 2026

Boston Scientific: The Time Has Come To Catch This Falling Knife

Seeking Alpha

Relative to its all-time high of $109.50 reached in September 2025, Boston Scientific Corporation's share price has declined by almost 60% to trade at around $45.00 per share. To put my money where my mouth is, I purchased my last shares on June 30th at an average price of $42.83.
My overall purchase price now stands at $45.52. As part of its Q1-26 earnings, Boston Scientific announced a significant outlook revision, reducing its organic growth guidance for fiscal 2026 to a range between 6.5% and 8.0%.

Read full article arrow
News Thumbnail
7:02 PM | Tuesday | Jun 30, 2026

Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research

In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% shift from the previous trading day.

Read full article arrow
News Thumbnail
1:18 PM | Thursday | Jun 25, 2026

Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity

Seeking Alpha

Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive threats, but fundamentals-based valuation now appears attractive. Growth in key segments like electrophysiology and Watchman has slowed due to increased competition, reimbursement cuts, and less impressive clinical trial data. Management now guides to sub-10% revenue growth (6.5%-8% for the year), but I still expect 7.5% annualized growth over five years and improving margins.

Read full article arrow
News Thumbnail
7:01 PM | Wednesday | Jun 24, 2026

Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks Investment Research

In the most recent trading session, Boston Scientific (BSX) closed at $44.46, indicating a -2.5% shift from the previous trading day.

Read full article arrow
News Thumbnail